Literature DB >> 27461103

Empowering Regulatory T Cells in Autoimmunity.

Isaac R Kasper1, Sokratis A Apostolidis2, Amir Sharabi3, George C Tsokos4.   

Abstract

Regulatory T cells (Tregs) are capable of dampening immune-mediated inflammation and avert the destructive effects of uncontrolled inflammation. Distinct molecules and pathways, including various transcription factors, phosphatases, and kinases, impact the ability of Tregs to function as negative regulators of the immune response, and are presumably amenable to therapeutic manipulation. Here, we discuss recently identified molecular networks and the therapeutic potential for treating autoimmune diseases.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27461103      PMCID: PMC5003773          DOI: 10.1016/j.molmed.2016.07.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  121 in total

1.  c-Rel is required for chromatin remodeling across the IL-2 gene promoter.

Authors:  Sudha Rao; Steve Gerondakis; Donna Woltring; M Frances Shannon
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

2.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

3.  Down-regulation of Tet2 prevents TSDR demethylation in IL2 deficient regulatory T cells.

Authors:  Varun Sasidharan Nair; Kwon Ik Oh
Journal:  Biochem Biophys Res Commun       Date:  2014-06-28       Impact factor: 3.575

4.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

5.  FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice.

Authors:  Seiichiro Ando; Hirofumi Amano; Eri Amano; Kentaro Minowa; Takashi Watanabe; Soichiro Nakano; Yutaka Nakiri; Shinji Morimoto; Yoshiaki Tokano; Qingshun Lin; Rong Hou; Mareki Ohtsuji; Hiromichi Tsurui; Sachiko Hirose; Yoshinari Takasaki
Journal:  Biochem Biophys Res Commun       Date:  2010-03-15       Impact factor: 3.575

6.  Novel Foxo1-dependent transcriptional programs control T(reg) cell function.

Authors:  Weiming Ouyang; Will Liao; Chong T Luo; Na Yin; Morgan Huse; Myoungjoo V Kim; Min Peng; Pamela Chan; Qian Ma; Yifan Mo; Dies Meijer; Keji Zhao; Alexander Y Rudensky; Gurinder Atwal; Michael Q Zhang; Ming O Li
Journal:  Nature       Date:  2012-11-07       Impact factor: 49.962

7.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

8.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

Review 9.  Metabolic regulation of regulatory T cell development and function.

Authors:  David John Coe; Madhav Kishore; Federica Marelli-Berg
Journal:  Front Immunol       Date:  2014-11-18       Impact factor: 7.561

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  23 in total

1.  Regulatory T cells: exploring mechanisms for future therapies.

Authors:  C A Piccirillo
Journal:  Clin Exp Immunol       Date:  2019-07       Impact factor: 4.330

Review 2.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

Review 3.  Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.

Authors:  Vaishali R Moulton; Abel Suarez-Fueyo; Esra Meidan; Hao Li; Masayuki Mizui; George C Tsokos
Journal:  Trends Mol Med       Date:  2017-06-13       Impact factor: 11.951

Review 4.  Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.

Authors:  David A Horwitz; Tarek M Fahmy; Ciriaco A Piccirillo; Antonio La Cava
Journal:  Trends Immunol       Date:  2019-10-07       Impact factor: 16.687

Review 5.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

6.  Reduced frequency of circulating regulatory T cells and their related immunosuppressive mediators in treated celiac patients.

Authors:  Nastaran Asri; Mohammad Rostami-Nejad; Abdolrahim Nikzamir; Elham Aghamohamadi; Hamid Asadzadeh-Aghdaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2022-06-20       Impact factor: 2.742

Review 7.  T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy.

Authors:  Amir Sharabi; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2020-01-16       Impact factor: 20.543

8.  Soluble fibrinogen‑like protein 2 levels are decreased in patients with ischemic heart failure and associated with cardiac function.

Authors:  Ya You; Shiyuan Huang; Hui Liu; Cheng Fan; Kun Liu; Zhaohui Wang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

9.  Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells.

Authors:  Jin-Kwan Lee; Seo-Young Koo; Hye-Mi Nam; Jee-Boong Lee; Jiwon Ko; Kyung-Mo Kim; Eun-Ji Park; Tae Jin Kim; Ho Lee; Heounjeong Go; Chang-Woo Lee
Journal:  Cell Mol Immunol       Date:  2021-04-13       Impact factor: 22.096

Review 10.  Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases.

Authors:  Guan Yang; Yaoyao Xia; Wenkai Ren
Journal:  Sci China Life Sci       Date:  2020-07-13       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.